Portage Biotech, Inc. has announced the re-launch of its subsidiary, Cyncado Therapeutics, which will operate independently to focus on developing adenosine receptor antagonists aimed at improving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback